These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8290248)
21. A novel slow-tight binding serine protease inhibitor from eastern oyster (Crassostrea virginica) plasma inhibits perkinsin, the major extracellular protease of the oyster protozoan parasite Perkinsus marinus. Xue QG; Waldrop GL; Schey KL; Itoh N; Ogawa M; Cooper RK; Losso JN; La Peyre JF Comp Biochem Physiol B Biochem Mol Biol; 2006 Sep; 145(1):16-26. PubMed ID: 16872855 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184 [TBL] [Abstract][Full Text] [Related]
23. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390 [TBL] [Abstract][Full Text] [Related]
24. The interaction of human tryptase-beta with small molecule inhibitors provides new insights into the unusual functional instability and quaternary structure of the protease. Selwood T; Smolensky H; McCaslin DR; Schechter NM Biochemistry; 2005 Mar; 44(9):3580-90. PubMed ID: 15736967 [TBL] [Abstract][Full Text] [Related]
25. Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5. Hou J; Clemmons DR; Smeekens S J Cell Biochem; 2005 Feb; 94(3):470-84. PubMed ID: 15534875 [TBL] [Abstract][Full Text] [Related]
26. Crystal structure of a novel viral protease with a serine/lysine catalytic dyad mechanism. Feldman AR; Lee J; Delmas B; Paetzel M J Mol Biol; 2006 May; 358(5):1378-89. PubMed ID: 16584747 [TBL] [Abstract][Full Text] [Related]
27. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies. Sun J; Pons J; Craik CS Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907 [TBL] [Abstract][Full Text] [Related]
28. Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin. Zhang JL; Zhao WG; Wu KL; Wang K; Zhang X; Gu CF; Li Y; Zhu Y; Wu JG Arch Virol; 2005 Apr; 150(4):721-41. PubMed ID: 15614436 [TBL] [Abstract][Full Text] [Related]
29. Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro. Stallmach R; Gloor SM Biochem J; 2008 May; 412(1):81-91. PubMed ID: 18215125 [TBL] [Abstract][Full Text] [Related]
30. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Henkler F; Waseem N; Golding MH; Alison MR; Koshy R Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397 [TBL] [Abstract][Full Text] [Related]
31. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition. Cercek L; Cercek B Cancer Detect Prev; 1993; 17(3):447-54. PubMed ID: 7691406 [TBL] [Abstract][Full Text] [Related]
32. A Kunitz-type proteinase inhibitor from the midgut of the ixodid tick, Haemaphysalis longicornis, and its endogenous target serine proteinase. Miyoshi T; Tsuji N; Islam MK; Alim MA; Hatta T; Yamaji K; Anisuzzaman ; Fujisaki K Mol Biochem Parasitol; 2010 Apr; 170(2):112-5. PubMed ID: 20026198 [TBL] [Abstract][Full Text] [Related]
33. Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein. Avril LE; Di Martino-Ferrer M; Barin F; Gauthier F FEBS Lett; 1993 Feb; 317(1-2):167-72. PubMed ID: 8428626 [TBL] [Abstract][Full Text] [Related]
34. Molecular basis of proteolytic activation of Sendai virus infection and the defensive compounds for infection. Kido H; Beppu Y; Sakai K; Towatari T Biol Chem; 1997; 378(3-4):255-63. PubMed ID: 9165079 [TBL] [Abstract][Full Text] [Related]
35. A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II). Janc JW; Clark JM; Warne RL; Elrod KC; Katz BA; Moore WR Biochemistry; 2000 Apr; 39(16):4792-800. PubMed ID: 10769136 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in research on tryptases and endogenous tryptase inhibitors. Katunuma N; Kido H Monogr Allergy; 1990; 27():51-66. PubMed ID: 2150689 [No Abstract] [Full Text] [Related]
37. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization. Kido H; Fukutomi A; Katunuma N J Biol Chem; 1990 Dec; 265(35):21979-85. PubMed ID: 1979328 [TBL] [Abstract][Full Text] [Related]
38. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses. Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405 [TBL] [Abstract][Full Text] [Related]
39. Structure and function of invertebrate Kunitz serine protease inhibitors. Ranasinghe S; McManus DP Dev Comp Immunol; 2013 Mar; 39(3):219-27. PubMed ID: 23186642 [TBL] [Abstract][Full Text] [Related]
40. Detection of tryptase TL2 and CD26 antigen in brain-derived cells non-permissive to T-cell line-tropic human immunodeficiency virus type 1. Shimizu N; Kobayashi M; Liu HY; Kido H; Hoshino H FEBS Lett; 1995 Jan; 358(1):48-52. PubMed ID: 7821428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]